Literature DB >> 2947698

Rhamnolipid from Pseudomonas aeruginosa inactivates mammalian tracheal ciliary axonemes.

A T Hastie, S T Hingley, M L Higgins, F Kueppers, T Shryock.   

Abstract

Isolated ciliary axonemes from pig trachea were exposed to increasing concentrations of purified Pseudomonas aeruginosa rhamnolipid. This is a defined ciliary system allowing observation of direct impairment of functional axonemes. Axonemal motility and ATPase activity were decreased in proportion to rhamnolipid concentrations. ATPase-associated proteins observed in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and dynein arms seen in ultra-structural cross sections progressively disappeared from axonemes with exposure to rhamnolipid. These four independent measures establish that the rhamnolipid removes the ATPase-containing outer dynein arms from the ciliary axoneme, thereby rendering the axoneme immotile.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2947698     DOI: 10.1002/cm.970060509

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  3 in total

1.  Pseudomonas aeruginosa possesses two putative type I signal peptidases, LepB and PA1303, each with distinct roles in physiology and virulence.

Authors:  Richard D Waite; Ruth S Rose; Minnie Rangarajan; Joseph Aduse-Opoku; Ahmed Hashim; Michael A Curtis
Journal:  J Bacteriol       Date:  2012-06-22       Impact factor: 3.490

2.  Rhamnolipids modulate swarming motility patterns of Pseudomonas aeruginosa.

Authors:  Nicky C Caiazza; Robert M Q Shanks; G A O'Toole
Journal:  J Bacteriol       Date:  2005-11       Impact factor: 3.490

Review 3.  Potential Therapeutic Targets for Combination Antibody Therapy against Pseudomonas aeruginosa Infections.

Authors:  Luke L Proctor; Whitney L Ward; Conner S Roggy; Alexandra G Koontz; Katie M Clark; Alyssa P Quinn; Meredith Schroeder; Amanda E Brooks; James M Small; Francina D Towne; Benjamin D Brooks
Journal:  Antibiotics (Basel)       Date:  2021-12-14
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.